[Expert recommendations on the first-line use and optimization plan of nucleos(t)ide analogues in the context of functional cure for chronic hepatitis B]. [PDF]
Liver Cancer Study Group +2 more
europepmc +1 more source
[Exploration of antiviral regimens for patients with chronic hepatitis B virus infection in the indeterminate phase]. [PDF]
Zheng J +8 more
europepmc +1 more source
[Recent advances in epidemiology, prevention and treatment of hepatitis C in China]. [PDF]
Yu JJ +7 more
europepmc +1 more source
[Chemotherapy-related central nervous system injury in children with acute lymphoblastic leukemia: research progress]. [PDF]
Wang L +5 more
europepmc +1 more source
[Effect of switching from entecavir to tenofovir amibufenamide on HBsAg levels in patients with chronic hepatitis B: a 96-week real-world study]. [PDF]
Wang LL +6 more
europepmc +1 more source
[Interpretation of key updates of the 2026 version of the APASL clinical practice guidelines for the management of chronic hepatitis B]. [PDF]
Liu HS, Ai XW, Sun YM, You H.
europepmc +1 more source
[Distribution of serum HBV RNA in the natural history of chronic HBV infection and factors influencing HBV RNA negativity: a retrospective study stratified by HBeAg status]. [PDF]
Li YJ +8 more
europepmc +1 more source
[Clinical significance and occurrence mechanism of hepatitis B virus DNA integration]. [PDF]
Shi YJ, Zhang KX, Li MY, Lu DJ, Chen XM.
europepmc +1 more source
[CRISPR-Cas9 activation screening identifies candidate chemokine regulators of ter-tiary lymphoid structure formation in bladder cancer]. [PDF]
Wang Y, Song H, DU Y, Xu T.
europepmc +1 more source
[Advances in growth impairment associated with pediatric respiratory diseases]. [PDF]
Chen XW, Chen DH.
europepmc +1 more source

